ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Sr. Director - eCOA Program Lead at Eli Lilly and Company - ApplyBlast

Sr. Director - eCOA Program Lead

Eli Lilly and Company

4 months ago

4.0 on Glassdoor

Indianapolis, IN

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The ECOA Program Lead serves as the senior point of contact for electronic Clinical Outcome Assessment programs within a specific therapeutic area at Eli Lilly. This role involves shaping the delivery and governance of eCOA strategies, advising clinical development leaders, and ensuring alignment with regulatory standards like GCP and 21 CFR Part 11. The professional drives operational excellence by managing cross-functional issues, mentoring colleagues, and continuously improving platform capabilities.

Responsibilities

Serve as primary eCOA authority for the assigned therapeutic area
Develop and implement eCOA delivery strategies aligned with platform capabilities
Manage escalation and resolution of complex cross-functional issues
Ensure inspection readiness and alignment with regulatory quality requirements
Mentor junior colleagues and drive process improvement initiatives

Skills

Qualifications

Bachelor's degree in life sciences or related STEM fieldMasters in life sciences or related STEM field10+ years of experience in clinical drug development7+ years of experience with Masters degree

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.